CAPHRA calls out FCTC’s “Myths vs Facts” Campaign that Ignores Real-World THR Success

Notified -

Gordon Brothers Serves as International Agent for $126M Financing Package to Support Valore Holdings’ Acquisition of Mirai Casting Group

Notified -

OFC 2026 Show Floor Programs Deliver Essential Insights on Market Direction and Breakthrough Technologies

Notified -

LYB announces updated 2030 sustainability goals

Notified -

Enigmatig Reports 12.2% Revenue Growth and 68.8% Gross Margin in Fiscal 2025 Following NYSE American Listing

Notified -

Invitation: Ascom 2025 Full-Year Results Conference for analysts and investors

Notified -

Tune Talk Becomes ASEAN’s First Fully Cloud-Native Mobile Network Operator with Mavenir

Notified -

Best Places to Work Certification Recognizes Asia-Pacific Organizations for Workplace Excellence

Notified -

‘The Jay Walker Podcast’ to premiere Globally on Tubi this summer

Notified -

Founder Group Limited Receives NASDAQ Notification Regarding Minimum Publicly Held Shares Deficiency

Notified -

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Notified -

WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook

Notified -